CZ211299A3 - Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů - Google Patents

Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů Download PDF

Info

Publication number
CZ211299A3
CZ211299A3 CZ992112A CZ211299A CZ211299A3 CZ 211299 A3 CZ211299 A3 CZ 211299A3 CZ 992112 A CZ992112 A CZ 992112A CZ 211299 A CZ211299 A CZ 211299A CZ 211299 A3 CZ211299 A3 CZ 211299A3
Authority
CZ
Czechia
Prior art keywords
vvf
factor
derivative
von
von villebrand
Prior art date
Application number
CZ992112A
Other languages
Czech (cs)
English (en)
Inventor
Hans-Peter Schwarz
Peter Turecek
Johann Eibl
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Publication of CZ211299A3 publication Critical patent/CZ211299A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
CZ992112A 1996-12-13 1997-11-19 Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů CZ211299A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0217896A AT405740B (de) 1996-12-13 1996-12-13 Von willebrand-faktor-derivat sowie ein verfahren zur isolierung von proteinen

Publications (1)

Publication Number Publication Date
CZ211299A3 true CZ211299A3 (cs) 1999-09-15

Family

ID=3529390

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ992112A CZ211299A3 (cs) 1996-12-13 1997-11-19 Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů

Country Status (6)

Country Link
EP (1) EP0954533A1 (de)
JP (1) JP2001506987A (de)
AT (1) AT405740B (de)
CZ (1) CZ211299A3 (de)
HU (1) HUP9903789A3 (de)
WO (1) WO1998025969A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994310A (en) * 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
DK1835938T3 (da) 2004-12-27 2013-11-04 Baxter Int Polymer-von Willebrand-faktor-konjugater
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
EP2010222A1 (de) 2006-03-31 2009-01-07 Baxter International Inc. Pegylierter faktor viii
HRP20130414T1 (en) * 2008-10-21 2013-06-30 Baxter International Inc. Lyophilized recombinant vwf formulations
KR20140131957A (ko) * 2012-02-14 2014-11-14 포톨라 파마슈티컬스, 인코포레이티드 Xa 인자 억제제에 대한 재조합 해독제를 제조하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
DE19521313A1 (de) * 1995-06-12 1996-12-19 Max Planck Inst Fuer Physiolog Verfahren zur affinitätschromatographischen Aufreinigung von Faktor VIII
SE9503380D0 (sv) * 1995-09-29 1995-09-29 Pharmacia Ab Protein derivatives

Also Published As

Publication number Publication date
JP2001506987A (ja) 2001-05-29
HUP9903789A2 (hu) 2000-03-28
EP0954533A1 (de) 1999-11-10
ATA217896A (de) 1999-03-15
AT405740B (de) 1999-11-25
WO1998025969A1 (de) 1998-06-18
HUP9903789A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
AU645172B2 (en) Process for an industrial-scale preparation of a standardized human von Willebrand factor concentrate of very high purity and suitable for therapeutic use
US5202253A (en) Monoclonal antibody specific for protein C and antibody purification method
US5245014A (en) Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions
FI101476B (fi) Menetelmä kalsiumista riippuvan proteiini C:n vastaisen monoklonaalise n vasta-aineen valmistamiseksi
JP4250769B2 (ja) 高度に精製されたｖＷＦまたは因子ＶＩＩＩ／ｖＷＦ複合体を得る方法
JPH09221432A (ja) フォンビルブラント因子を含む医薬調製物
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
CZ211299A3 (cs) Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů
US20020019036A1 (en) Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor
US5710254A (en) Purification of von Willebrand factor by affinity chromatography
RU2734783C2 (ru) Способ отделения фактора viii от продуктов крови
Thomas Studies on the third component of complement
de Lille Burnouf-Radosevich et a1.
Canfield THE PROTEOLYTIC ACTIVATION AND INACTIVATION OF BOVINE COAGULATION FACTOR V (HEMOSTASIS)
MXPA97003470A (en) Factor v purification process

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic